HBM

Summary

Hold core HBM at 28.55; do not add or chase. Risk/reward is balanced after a 41.4% run to 30.79 and a 7.3% pullback. Size for ATR 1.34 (4.7% daily mover) and reduce position size accordingly. Key levels: resistance at 28.96 (10 EMA) must be reclaimed for momentum to re-expand, with support cluster at 28.49 VWMA / 27.97 Bollinger middle. Add only on a settled close >28.96 with RSI>50 and MACD histogram expanding, or on a washout to 27.97-26.50 with volume confirmation. Risk management: a settled close below 27.97 on expanding volume calls for trimming the position, with swing stop at 27.20 (1x ATR) and trend stop at 24.50 below the 50 SMA. Use defined-risk spreads given IV 69.8% and beta 2.265; avoid naked calls/puts. Horizon is 5 days neutral while awaiting copper/COPX resolution.

The case

Primary uptrend remains intact (28.55 > 50 SMA 24.75 > 200 SMA 23.29, rising 200 SMA) but short-term momentum has broken: first close below 10 EMA 28.96, 10 EMA turned down to 28.95, RSI bearish divergence (70.26 vs 69.72) then 14pt drop to 56.36, MACD 1.44 vs 1.41 histogram 0.04 near bearish cross. Our analysis views this as a healthy 7.3% consolidation after a 41.4% rip, still above VWMA 28.49 and Bollinger middle 27.97, with RSI>50, MACD positive, and low partial volume 740k vs 4.97M showing no distribution yet. At the same time, the bar is still open, cushion to support is <0.5x ATR 1.34, and failure below 27.97 opens an air pocket to 26.41 then 24.68 (-13.5%). Sentiment is crowded — the 20-0 ratio at 20.0 on social sentiment channels and crowd reading at 74 — but anchored to copper leverage and COPX as 2nd largest holding, providing a structural bid while copper holds and symmetric redemption risk if copper fades; put/call volume 1.46 vs OI 0.16 reflects tactical hedging not a strategic flip, but IV 69.8% makes chasing poor. Fundamentals: TTM is distorted by Q3 322.6M impairment reversal (reported 222.4M vs normalized -6M), but the normalized rebound is real — Q4 76.9M, Q1 159.3M, Q2 108.2M, with margins recovered to healthy levels, OCF 2.15x, FCF 450M TTM, forward P/E 14.54 vs TTM 17.52, target 32.60 (+14.2%). Balance sheet is de-risked (net debt ~0, current ratio 2.24, debt 913M vs 1136M, current debt zero) but funded by 12.2% dilution (395.7M to 444.1M shares) and 43% PPE growth to 6.19B with 1.42B CIP execution risk. Beta 2.265 amplifies moves in both directions. With a market fear gauge at 50 neutral, there is no broad market cushion. Net: no edge to Buy or Sell at 28.55 — Hold and wait for a volume-confirmed reclaim or washout.

What would weaken it

• Close below 27.97 opens air pocket to 26.41 then 24.68 (-13.5%)
• Beta 2.265 amplifies downside; copper/COPX redemption risk if copper fades
• High IV 69.8% and 43% PPE growth to 6.19B add execution/volatility risk